- Home
- BLTE vs ATGE Comparison
BLTE vs ATGE Comparison
Compare BLTE & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLTE | ATGE |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.8B |
| IPO Year | 2022 | 1991 |
Fundamental Metrics
Financial Performance| Metric | BLTE | ATGE |
|---|---|---|
| Price | $169.05 | $106.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $161.57 | $145.67 |
| AVG Volume (30 Days) | 237.7K | ★ 361.2K |
| Earning Date | 03-16-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.41 |
| EPS | N/A | ★ 6.76 |
| Revenue | N/A | ★ $1,888,834,000.00 |
| Revenue This Year | N/A | $9.83 |
| Revenue Next Year | N/A | $6.11 |
| P/E Ratio | ★ N/A | $17.10 |
| Revenue Growth | N/A | ★ 11.92 |
| 52 Week Low | $49.00 | $86.26 |
| 52 Week High | $174.78 | $156.26 |
Technical Indicators
Market Signals| Indicator | BLTE | ATGE |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 40.91 |
| Support Level | $156.52 | $115.50 |
| Resistance Level | $171.63 | $124.11 |
| Average True Range (ATR) | 8.88 | 4.95 |
| MACD | 0.26 | -1.03 |
| Stochastic Oscillator | 79.00 | 21.41 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About ATGE Adtalem Global Education Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.